Table 1.
Depicts clinical data of our patient over the observation period
| 2012 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|
| Clinical examination | ||||
| Coutinho stage | 1 | 2 | 2 | 2 |
| mNIS7 score | 31 | 149.5 | 183.5 | 172.5 |
| Nerve conduction studies | ||||
| Medial nerve, sensory |
SNAP: 8 µV NCV: 52 m/s |
Absent | Absent | Absent |
| Medial nerve, motor |
CMAP: 11 mV NCV: 54 m/s |
CMAP: 4.8 mV NCV: 48 m/s |
CMAP: 0.9 mV NCV: 44 m/s |
CMAP: 0.6 mV NCV: 46 m/s |
| Sural nerve | Absent | Absent | Absent | Absent |
| Peroneal nerve |
CMAP: 2.5 mV NCV: 41 m/s |
Absent | Absent | Absent |
| Tibial nerve |
CMAP: 8.0 mV NCV: 43 m/s |
CMAP: 0.9 mV NCV: 38 m/s |
Absent | Absent |
| Cardiological examinations | ||||
| NYHA stadium | I–II | I–II | I–II | I–II |
| Septal thickness | 16 mm | 17 mm | 18 mm | 20 mm |
| Ejection fraction | 52% | 55% | 55% | 71% |
SNAP sensory nerve action potential, NCV nerve conduction velocity, CMAP compound muscle action potential